Christos Adamopoulos

15PUBLICATIONS
39CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Tumour immunologyArtificial life and complex adaptive systemsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 29, 2026
Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition.

|Jul 28, 2026
The Role of AP-1 in Cancer: Regulation, Tumor Microenvironment and Therapeutic Targeting.

|Jun 13, 2026
The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities.

|Jan 10, 2026
Targeting the MAPK Pathway in Brain Tumors: Mechanisms and Therapeutic Opportunities.

Dimitrios Vrachas, Elisavet Kosma, Angeliki-Ioanna Giannopoulou

|Oct 15, 2025
RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors.

Beau Baars, Ana Orive-Ramos, Matthew J Emmett

|Oct 06, 2025
SUV39H1 regulates progression of pediatric diffuse high-grade gliomas through modulation of β-catenin/TCF4 levels.

Alexia Klonou, Angeliki-Ioanna Giannopoulou, Christos Adamopoulos

Pageof 3

Frequent Collaborators

9 joint publications

Donatella Delle Cave

5 joint publications

Antonios N Gargalionis

4 joint publications

Christina Piperi

3 joint publications

Kostas A Papavassiliou